Battler - thanks for posting the Article.
Dr Levin further enhanced his reputation as a astute playmaker in the Biotech / Pharma space, with his well known "String of Pearls" strategy whilst his time at Bristol-Myers Squibb's , which was aimed to make sequential transactions to secure compounds, pipeline or entire companies to fill specific pipeline gaps.
Here is the reference.
Jeremy Levin - The 25 most influential people in biopharma today.
http://www.fiercebiotech.com/special-reports/25-most-influential-people-biopharma-today/jeremy-levin-25-most-influential-people-b.
Interesting times ahead.
DYOR.
leadership change at teva provides catalyst , page-2
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.47 |
Change
-0.045(2.98%) |
Mkt cap ! $1.672B | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.50 | $1.45 | $8.307M | 5.669M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 151320 | $1.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.47 | 55652 | 2 |
View Market Depth
| Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |